Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
W.A. Wuyts
Observed names:
W Wuyts,
W. Wuyts,
WA Wuyts
Institution:
Universitair Ziekenhuis Leuven
Observed institutions:
Rega Institute for Medical Research,
Universitair Ziekenhuis Leuven,
KU Leuven
OpenAlex ID:
A5113878962
Is Lung Transplantation a Valuable Therapeutic Option for Patients With Pulmonary Polymyositis? Experiences From the Leuven Transplant Cohort
2014
·
H. Ameye
, D. Ruttens
, et al.
·
Transplantation Proceedings
·
36
Presence of δ-( l -α-Aminoadipyl)- l -Cysteinyl- d -Valine in Fermentations of Penicillium chrysogenum
1975
·
P. Adriaens
, B. Meesschaert
, et al.
·
Antimicrobial Agents and Chemotherapy
·
33
Separation of ninhydrin-positive compounds on a single-column amino acid analyzer using lithium buffers
1977
·
P. Adriaens
, B. Meesschaert
, et al.
·
Journal of Chromatography A
·
19
Effect of dose reductions and/or interruptions on the efficacy of nintedanib in patients with idiopathic pulmonary fibrosis (IPF): subgroup analysis of the INPULSIS trials
2018
·
D Koschel
, TM Maher
, et al.
·
Pneumologie
·
11
Solid Organ Transplantation in Sarcoidosis
2017
·
J. Yserbyt
, W. Wuyts
, et al.
·
Seminars in Respiratory and Critical Care Medicine
·
8
PDF
Rationale, Design and Objectives of Two Phase III, Randomised, Placebo-Controlled Studies of GLPG1690, a Novel Autotaxin Inhibitor, in Idiopathic Pulmonary Fibrosis (ISABELA 1 and 2)
2019
·
T.M. Maher
, M. Kreuter
, et al.
·
5
M30 Effect of dose reductions and/or interruptions on the efficacy of nintedanib in patients with idiopathic pulmonary fibrosis (ipf): subgroup analysis of the inpulsis trials
2017
·
TM Maher
, Y Inoue
, et al.
·
5
PDF
Development and Validation of Machine-learned Algorithms for Diagnosing ASMD Among Patients With Unexplained ILD
2025
·
I. Noth
, F. Bonella
, et al.
·
American Journal of Respiratory and Critical Care Medicine
·
1
Intrafamilial Correlation and Variability in the Clinical Evolution of Pulmonary Fibrosis
2023
·
T. Goos
, A. Dubbeldam
, et al.
·
1
Efficacy and Safety of Nintedanib in Elderly Patients with Progressive Fibrosing Interstitial Lung Diseases (ILDs)
2022
·
T. Moua
, F. Bonella
, et al.
·
1
Effects of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis and Varying Severities of Cough
2021
·
W.A. Wuyts
, C. Vancheri
, et al.
·
1
PDF
Efficacy and Safety of Sildenafil Added to Pirfenidone in Patients with Advanced Idiopathic Pulmonary Fibrosis (IPF) and Risk of Pulmonary Hypertension (PH)
2020
·
J. Behr
, S.D. Nathan
, et al.
·
1
Efficacy and Safety of Nintedanib in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease: Subgroup Analysis of the SENSCIS Trial by Corticosteroid Use*
2020
·
R Wiewrodt
, M Vonk
, et al.
·
Pneumologie
·
1
Pharmacokinetics (PK) of nintedanib with add-on pirfenidone in patients with idiopathic pulmonary fibrosis (IPF): results from INJOURNEY
2018
·
M Kreuter
, WA Wuyts
, et al.
·
Pneumologie
·
1
Fibroblast Activation Protein as a Novel Target for Chronic Lung Allograft Dysfunction
2026
·
M. Mercurio
, P. Kerckhof
, et al.
·
The Journal of Heart and Lung Transplantation
Reversal of Interstitial Lung Disease in Children and Adults With Chronic Acid Sphingomyelinase Deficiency Treated With Olipudase Alfa Enzyme Replacement Therapy
2025
·
G. Raghu
, M. Scarpa
, et al.
·
American Journal of Respiratory and Critical Care Medicine
Clinical Revalence of Diffusing Lung Capacity for Carbon Monoxide (DLco) in Patients with Acid Sphingomyelinase Disease (ASMD): A Post-hoc Analysis
2025
·
F Bonella
, W Wuyts
, et al.
·
Pneumologie
Identifikation von Core Outcomes für Pulmonale Fibrose in einem kollaborativen Ansatz: Erste Ergebnisse aus dem COCOS-IPF Projekt
2025
·
V Somogyi
, S Schenk
, et al.
·
Pneumologie
Single Nuclear RNAseq of Differentially Affected IPF Lung Uncovers Potential Cellular Origins of Aberrant Basaloid Cells
2023
·
T.S. Adams
, J.C. Schupp
, et al.
Correspondence Between Audible Crackles and Lung Function Test Results
2023
·
S. Gogaert
, T. Goos
, et al.
PDF
Efficacy and safety of nintedanib in elderly patients with progressive fibrosing interstitial lung diseases (ILDs)*
2023
·
F Bonella
, T Moua
, et al.
·
Pneumologie
A Probabilistic Graphical Model for Understanding Cellular Dynamics in Idiopathic Pulmonary Fibrosis Progression
2022
·
J. Ding
, Y. Zheng
, et al.
Lung Cancer in Patients with Idiopathic Pulmonary Fibrosis: A Retrospective Multicenter Study in Europe
2022
·
T. Karampitsakos
, P. Spagnolo
, et al.
Single Nuclei RNA Sequencing of Differentially Affected Regions in IPF Lungs Suggests a Central Role of Aberrant Basaloid Cells in Disease Progression
2022
·
J.C. Schupp
, G. Clair
, et al.
PDF
Long-Term Pirfenidone for Restrictive Allograft Syndrome: A Case Series
2022
·
H. Beeckmans
, A. Sacreas
, et al.
·
The Journal of Heart and Lung Transplantation
Show more works
View as search
Works count:
30
Citation count:
124
H-index:
5
I10-index:
4
Year
Topic
Type